日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

(18)F-FPP-RGD(2) PET Imaging for Interrogating Target Engagement and Antifibrotic Activity of an Integrin Antagonist in a Mouse Model of Metabolic Dysfunction-Associated Steatohepatitis

(18)F-FPP-RGD(2) PET成像用于研究整合素拮抗剂在代谢功能障碍相关脂肪性肝炎小鼠模型中的靶点结合和抗纤维化活性

Zhou, Iris Y; Zhang, Caiyuan; Sojoodi, Mozhdeh; Rotile, Nicholas J; Lan, Yu; Barrett, Stephen C; Wang, Changning; Schaefer, Caralee J; Kossen, Karl; Seiwert, Scott D; Tanabe, Kenneth K; Caravan, Peter

Genome-wide imputation study identifies novel HLA locus for pulmonary fibrosis and potential role for auto-immunity in fibrotic idiopathic interstitial pneumonia

全基因组推断研究发现了一个新的肺纤维化HLA位点,并揭示了自身免疫在纤维化特发性间质性肺炎中的潜在作用。

Fingerlin, Tasha E; Zhang, Weiming; Yang, Ivana V; Ainsworth, Hannah C; Russell, Pamela H; Blumhagen, Rachel Z; Schwarz, Marvin I; Brown, Kevin K; Steele, Mark P; Loyd, James E; Cosgrove, Gregory P; Lynch, David A; Groshong, Steve; Collard, Harold R; Wolters, Paul J; Bradford, Williamson Z; Kossen, Karl; Seiwert, Scott D; du Bois, Roland M; Garcia, Christine Kim; Devine, Megan S; Gudmundsson, Gunnar; Isaksson, Helgi J; Kaminski, Naftali; Zhang, Yingze; Gibson, Kevin F; Lancaster, Lisa H; Maher, Toby M; Molyneaux, Philip L; Wells, Athol U; Moffatt, Miriam F; Selman, Moises; Pardo, Annie; Kim, Dong Soon; Crapo, James D; Make, Barry J; Regan, Elizabeth A; Walek, Dinesha S; Daniel, Jerry J; Kamatani, Yoichiro; Zelenika, Diana; Murphy, Elissa; Smith, Keith; McKean, David; Pedersen, Brent S; Talbert, Janet; Powers, Julia; Markin, Cheryl R; Beckman, Kenneth B; Lathrop, Mark; Freed, Brian; Langefeld, Carl D; Schwartz, David A

Association between the MUC5B promoter polymorphism and survival in patients with idiopathic pulmonary fibrosis.

MUC5B启动子多态性与特发性肺纤维化患者生存率之间的关联

Peljto Anna L, Zhang Yingze, Fingerlin Tasha E, Ma Shwu-Fan, Garcia Joe G N, Richards Thomas J, Silveira Lori J, Lindell Kathleen O, Steele Mark P, Loyd James E, Gibson Kevin F, Seibold Max A, Brown Kevin K, Talbert Janet L, Markin Cheryl, Kossen Karl, Seiwert Scott D, Murphy Elissa, Noth Imre, Schwarz Marvin I, Kaminski Naftali, Schwartz David A

Danoprevir monotherapy decreases inflammatory markers in patients with chronic hepatitis C virus infection.

达诺普韦单药治疗可降低慢性丙型肝炎病毒感染患者的炎症标志物

Schaefer Caralee J, Kossen Karl, Lim Sharlene R, Lin Jiing-Huey, Pan Lin, Bradford Williamson, Smith Patrick F, Seiwert Scott D